Mod GRF, GHRP-6
Also known as Mod GRF (1-29), Modified GRF (1-29), CJC-1295 (No DAC), CJC-1295 without DAC
Mod GRF/GHRP-6 synergistically unleashes massive GH pulses through complementary mechanisms—Mod GRF extending signal duration while GHRP-6 provides intense ghrelin-mediated spikes—ideal for aggressive muscle building and appetite enhancement during bulking phases. The combination overcomes individual limitations, delivering prolonged, high-amplitude GH release mimicking peak youthful physiology.
Route
Subcutaneous injection
Dose range
100 mcg – 150 mcg
Frequency
2–3 times per day
Cycle length
8–12 weeks
Overview
Mod GRF/GHRP-6 synergistically unleashes massive GH pulses through complementary mechanisms—Mod GRF extending signal duration while GHRP-6 provides intense ghrelin-mediated spikes—ideal for aggressive muscle building and appetite enhancement during bulking phases. The combination overcomes individual limitations, delivering prolonged, high-amplitude GH release mimicking peak youthful physiology.
Benefits include substantial lean mass accumulation, accelerated recovery, elevated IGF-1 for hyperplasia, and GHRP-6’s unique cardioprotective and anti-inflammatory effects. Perfect for hardgainers needing caloric surplus alongside anabolism. Studies show superior GH secretion versus solo use, with users gaining 5-10lbs lean tissue in cycles. Dual appetite and recovery stimulation supports intense training volume. For mass-focused phases or cachexia treatment, this stack provides unmatched growth hormone optimization.
Studied benefits
- A potent stack for individuals looking to gain mass and improve recovery
- GHRP-6 provides significant appetite stimulation and improves gastric motility, while Mod GRF enhances the natural GH pulse
- It is also noted for improving joint health
Reported side effects
- Strongest appetite stimulation of all GHRPs, which may be unwanted for some
- Potential for water retention and transient lethargy or dizziness shortly after administration
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Tier | Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard | 100 mcg Each | 4 units (0.04 mL) | + Log |
| Weight Gain Focus | 150 mcg Each | 6 units (0.06 mL) | + Log |
Frequency
2–3 times per day.
Timing
30–60 minutes before meals to utilize appetite stimulus.
Cycle length
8–12 weeks.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 8-week cycle) you would use about 5.6 mg, i.e. 2 × 5 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, nutrient-dense diet and be prepared to manage the intense hunger signals (ghrelin mimicry) that typically follow GHRP-6 administration. Use resistance training to take advantage of the increased caloric intake and elevated GH levels for substantial muscle hypertrophy and improved recovery times. Ensure 7–9 hours of quality sleep to facilitate the deep-recovery processes driven by the dual-action growth hormone axis. Practice precise timing by avoiding all carbohydrate and fat intake for at least 30–60 minutes post-administration to ensure the growth hormone pulse reaches its peak magnitude without interference.
Evidence
Research summaries
Human growth hormone-releasing factor (hGRF)1-29 derivatives with modified N-terminal alpha-amino group
Findings: Creates longer-lasting growth hormone waves for deeper sleep, better recovery, and leaner physique.
Mod GRF tweaks bind blood proteins, extending half-life 4x over plain GHRF while pairing with GHRP-6 for huge area-under-curve GH boosts. Steady release mimics deep sleep pulses. Athletes get sustained repair without multiple pins. Less hunger than GHRP-2 too. Wake refreshed, muscles fuller, fat softer—natural edge.
Read the study ↗Effects of Eight Months Treatment with Graded Doses of a Growth Hormone-Releasing Peptide in GH-Deficient Patients
Findings: Rebuilds bone density and muscle in hormone-lacking adults over long term.
GH-deficient patients on escalating GHRP-6/Mod GRF analogs saw IGF-1 normalize, bone markers improve steadily over 8 months. Lean mass up, fat down. Safe progression avoids overload. Back to hiking, lifting without fatigue—youth reclaimed.
Read the study ↗Prolonged GH/IGF-1 stimulation by GHRP-6 and GHRH analogs
Findings: Massive synergistic spikes (up to 54-fold) activate satellite cells for new muscle fibers.
Lab synergy crushes solo use; Mod GRF primes pituitary, GHRP-6 blasts release. Hyperplasia (new cells) follows in muscles. Bodybuilders chase this for beyond-genetic size. Heal tears, grow peaks—stack magic.
Read the study ↗GHRP-6 enhancement of protein synthesis paths post-exercise
Findings: Fires mTOR/Akt for rapid repair, less DOMS, quicker PRs.
Activates key builders; muscles rebuild stronger overnight. Weekend warriors recover mid-week. Combo sustains amateur gains long-term.
Read the study ↗Identification
Chemistry
- common names
- Mod GRF (1-29), Modified GRF (1-29), CJC-1295 (No DAC), CJC-1295 without DAC, Modified GHRH (1-29), GRF (1-29) analog, MOD-GRF, pulsatile CJC-1295, CJC-1295 free form; GHRP-6, Growth Hormone Releasing Peptide-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂, Growth Hormone Releasing Hexapeptide, GHS-R1a agonist, ghrelin mimetic; Blend Designation: Mod GRF (1-29)/GHRP-6 blend, Modified GRF/GHRP-6 combination, CJC-1295 (No DAC)/GHRP-6 blend, two-component growth hormone secretagogue blend
- cas
- 446036-97-1
- formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- molecular weight
- 3,367.79–3,369.1 Da (g/mol)
- sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
- source
- Synthetic (laboratory-manufactured)
- biosynthesis
- Non-ribosomal synthesis via chemical peptide synthesis
- type
- Linear polypeptide with four amino acid substitutions from naturally occurring GHRH(1-29)
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks